ArticleTrials2024

UV light-mediated corneal crosslinking as (lymph)angioregressive pretreatment to promote graft survival after subsequent high-risk corneal transplantation (CrossCornealVision): protocol for a multicenter, randomized controlled trial.

Johanna Wiedemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.